Accuray, incorporated: a neurosurgical business case study.

Accuray Inc. (Sunnyvale, CA) designs, develops, and sells the CyberKnife Stereotactic Radiosurgery System, an image-guided radiosurgical instrument used to ablate diverse benign and malignant lesions. In 2001, Accuray received clearance from the Food and Drug Administration (FDA) to market the CyberKnife for radiosurgical treatment of lesions anywhere in the body where radiation is indicated. Since its inception in 1994, the CyberKnife has been used at 32 installations worldwide to treat more than 10,000 patients.